Skip to main content
Premium Trial:

Request an Annual Quote

GNI to Use Gene Regulatory Network Techology in Research Collaboration with Toyama Chemical

NEW YORK, Oct. 11 (GenomeWeb News) - Gene Networks International will provide its gene regulatory network technology platform to Toyama Chemical, the company said today.

 

GNI, which has offices in Kurume, Japan, and Cambridge, UK, has licensed the use of the technology to Toyamaand will provide the company with gene expression data and discovery services.

 

GNI's gene regulatory network maps are based on research at the Universityof Cambridge, KyushuUniversity, and the Universityof Tokyo.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more